Form 4: Tandem Diabetes Care Executive Elizabeth Gasser Reports Stock Transactions
SEC Form 4 Filing
EVP and Chief Strategy Officer Elizabeth Gasser reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units due to vesting and tax withholding.
Summary
- On August 15, 2024, Elizabeth Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care, reported transactions involving the company's common stock and restricted stock units (RSUs).
- These transactions included the acquisition of common stock upon the vesting of RSUs and the disposal of shares to cover tax withholding obligations.
- Specifically, 163, 474, and 1,503 shares were acquired through RSU vesting, while 59, 170, and 537 shares were disposed of to satisfy tax requirements at a price of $43.82 per share.
- Following these transactions, Gasser directly owns 1,374 shares of common stock and indirectly owns 11,749 shares through The Gasser Family Trust.
- She also directly owns 487, 1,423, and 10,522 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it's a factual report of transactions related to compensation.
Positives
- The vesting of RSUs indicates that performance milestones have been met, which could be seen as a positive sign.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages and equity-based incentives. These transactions are closely monitored by investors for insights into management's confidence in the company's future prospects.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry often include a mix of salary, bonuses, and equity-based compensation, such as stock options and restricted stock units.
- Vesting schedules for RSUs typically range from three to five years, with vesting occurring annually or quarterly.
- Tax withholding practices on RSU vesting are standard across publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
- However, investors may interpret these transactions as a reflection of management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 2011-09-01 | Date of The Gasser Family Trust |
| 2021-05-18 | Date RSUs were awarded pursuant to the 2013 Plan |
| 2022-05-15 | First vesting date for RSUs awarded on May 18, 2021 |
| 2022-05-25 | Date RSUs were awarded pursuant to the 2013 Plan |
| 2023-05-15 | First vesting date for RSUs awarded on May 25, 2022 |
| 2023-05-25 | Date RSUs were awarded pursuant to the 2023 Plan |
| 2024-05-15 | First vesting date for RSUs awarded on May 25, 2023 |
| 2024-08-15 | Date of reported stock transactions |
| 2024-08-19 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.